Related Experiment Video

Updated: Jun 2, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

Predictors of outcome in acute-on-chronic liver failure in children

Jeevan Lal1, B R Thapa, Pawan Rawal

  • 1Pediatric Gastroenterology, Hepatology and Nutrition, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India.

Hepatology International
|April 13, 2011
PubMed

Insights

Predicting survival in pediatric acute-on-chronic liver failure (ACLF) is crucial. The Sequential Organ Failure Assessment (SOFA) score and International Normalized Ratio (INR) effectively predict outcomes in children with ACLF.

Area of Science:

  • Pediatric Hepatology
  • Critical Care Medicine
  • Gastroenterology

Background:

  • Acute-on-chronic liver failure (ACLF) in children carries a high mortality risk.
  • Limited data exists on survival predictors for pediatric ACLF.
  • This study aimed to identify key prognostic factors in children with ACLF.

Purpose of the Study:

  • To prospectively investigate predictors of outcome in pediatric ACLF.
  • To establish reliable indicators for survival in children diagnosed with ACLF.

Main Methods:

  • Prospective evaluation of 31 children (1-16 years) meeting APASL 2008 ACLF criteria.
  • Assessment of etiology, diagnosis, and severity using the Sequential Organ Failure Assessment (SOFA) score.
  • Correlation analysis between various clinical variables and patient outcomes.

Main Results:

  • Autoimmune hepatitis and Wilson disease were common underlying conditions (41.9% each).
  • Hepatitis A virus (HAV) superinfection was the most frequent cause of acute decompensation (41.9%).
  • Multivariate analysis identified SOFA score and International Normalized Ratio (INR) as significant predictors of survival.

Conclusions:

  • Pediatric ACLF has a significant mortality rate of 19.4%, primarily due to multiorgan or liver failure.
  • The SOFA score and INR are valuable tools for predicting outcomes in pediatric ACLF.
  • These findings can aid in clinical decision-making and patient management for pediatric ACLF.
Abstract

More Related Videos

Extended 78% Hepatectomy in a Mouse Surgical Model05:25

Extended 78% Hepatectomy in a Mouse Surgical Model

Published on: May 24, 2024

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...